MDS Virtual Congress 2020 Archives - Page 24 of 149

Can post-operative local field potentials in the STN predict long-term DBS efficacy in Parkinson’s disease?

P.L Chen, H.T Wu, P.H Tu, Y.C Chen, C-C. Chen (Taoyuan City, Taiwan)
Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?

G. Baille, A. Kreisler, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)
Can we stage tau pathology in PSP?

G. Kovacs, M. Lukic, D. Irwin, T. Arzberger, G. Respondek, E. Lee, D. Coughlin, A. Giese, M. Grossman, C. Kurz, C. McMillan, E. Gelpi, Y. Compta, J. van Swieten, C. Troakes, S. Al-Sarraj, J. Robinson, S. Roeber, S. Xie, V. Lee, J. Trojanowski, G. Höglinger (Phildelphia, PA, USA)
Cancerous inhibitor of protein phosphatase 2A in Parkinson’s disease

S.J Yin, C. Han, T. Wang (Wuhan, China)
Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)
Canine Aromatic Detection of Parkinson’s Disease: Can Dogs Identify Prodromal Parkinsonism?

L. Mischley, J. Farahnik (Lake Forest Park, WA, USA)
CAPN1 mutations are more common than expected in patients with hereditary spastic paraparesis

G. Baille, A. Degardin, I. Strubi-Vuillaume, C. Tard (Lille, France)
Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy: A cross-sectional study

G. Ganagarajan, T.N Sathyaprabha, K. Udupa, M.R Raghurama, K. Kuravatti, B.S Prasad, R. Yadav, K. Kambhampati, P. John (Bangalore, India)
Cardiac Dysautonomia in Parkinson’s Disease

A. Carwin, S. Miri, S. Nakano, M. Anjum, E. Mundel, J. Starr, C. Marsh, B. Wilmarth, M. Arellano, H. Howard, M. Hebron, Y. Torres-Yaghi, C. Moussa, F. Pagan (Washington, DC, USA)
Cardiac Safety of PBT434, an Inhibitor of Alpha-Synuclein Aggregation for the Treatment of Multiple System Atrophy (MSA)

D. Stamler, M. Bradbury, C. Wong, E. Offman (Newark, CA, USA)